Literature DB >> 17342369

Prothrombin 20210 G/A defect as a cause of mesenteric venous infarction: report of a case.

Erdal Karagulle1, Emin Turk, Huseyin Savas Gokturk, Erkan Yildirim, Gokhan Moray.   

Abstract

A 50-year-old man with abdominal pain, nausea, and vomiting presented at our emergency department. Physical examination revealed diffuse abdominal tenderness and absent bowel sounds. Computed tomography showed partial portal vein thrombosis extending to the right portal vein and the superior mesenteric vein, perfusion defects in the liver, and nonopacified intestinal segment after contrast injection. An emergency laparotomy was performed. The wall of the distal jejunum was edematous, congested, and a 10-cm jejunal segment was necrotic. A partial intestinal resection and a primary anastomosis were performed. Screening for thrombophilia revealed a heterozygote 20210 G/A mutation of the prothrombin gene. Anticoagulation was initiated. Computed tomography 45 days after surgery showed a complete dissolution of the thrombi and cavernous transformation in the main portal vein. His subsequent clinical course was uneventful. Mesenteric venous thrombosis which causes an intestinal infarction is rare, and also difficult to diagnose. However, a prothrombin 20210 defect should be considered in the differential diagnosis of patients with unexplained thrombosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342369     DOI: 10.1007/s00595-006-3381-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  9 in total

Review 1.  Genetic susceptibility to venous thrombosis.

Authors:  U Seligsohn; A Lubetsky
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

2.  Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels.

Authors:  H Ceelie; R M Bertina; A van Hylckama Vlieg; F R Rosendaal; H L Vos
Journal:  Thromb Haemost       Date:  2001-06       Impact factor: 5.249

3.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

Authors:  S R Poort; F R Rosendaal; P H Reitsma; R M Bertina
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

4.  Geographic distribution of the 20210 G to A prothrombin variant.

Authors:  F R Rosendaal; C J Doggen; A Zivelin; V R Arruda; M Aiach; D S Siscovick; A Hillarp; H H Watzke; F Bernardi; A M Cumming; F E Preston; P H Reitsma
Journal:  Thromb Haemost       Date:  1998-04       Impact factor: 5.249

Review 5.  The Leiden Thrombophilia Study (LETS).

Authors:  F J van der Meer; T Koster; J P Vandenbroucke; E Briët; F R Rosendaal
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

6.  Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia.

Authors:  Nazim Ağaoğlu; Serdar Türkyilmaz; Ercüment Ovali; Fahri Uçar; Celal Ağaoğlu
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

Review 7.  The thrombophilias: well-defined risk factors with uncertain therapeutic implications.

Authors:  K A Bauer
Journal:  Ann Intern Med       Date:  2001-09-04       Impact factor: 25.391

8.  Mesenteric infarction due to combined protein C deficiency and prothrombin 20210 defects.

Authors:  C J Mainwaring; M Makris; W E Thomas; K K Hampton; F E Preston
Journal:  Postgrad Med J       Date:  1999-12       Impact factor: 2.401

9.  Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.

Authors:  A Gurgey; I C Haznedaroglu; T Egesel; Y Buyukasik; O I Ozcebe; N Sayinalp; S V Dundar; Y Bayraktar
Journal:  Am J Hematol       Date:  2001-06       Impact factor: 10.047

  9 in total
  1 in total

1.  Portal vein thrombosis due to factor 2 leiden in the post-operative course of a laparoscopic sleeve gastrectomy for morbid obesity.

Authors:  Bruno Berthet; Emilie Bollon; René Valero; Mehdi Ouaissi; Igor Sielezneff; Bernard Sastre
Journal:  Obes Surg       Date:  2009-07-15       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.